Clinical Trials Browser

Phase 2 × Active not recruiting × Interferon alpha-2 × Clear all

NCT01708941 2025-11-26

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Active not recruiting

88 enrolled 14 charts

Melanoma

NCT03899987 2025-08-27

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Phase 2 Active not recruiting

Prostatic Neoplasms